**Princess Kate and King Charles Unite for Cancer Research UK Anniversary**
:max_bytes(150000):strip_icc():format(jpeg)/kate-middleton-st-james-palace-1-060226-012a3b9c4f624faa8fd0c07449677981.jpg)

On June 2, 2026, a poignant royal reception took place at St. James’s Palace in London, marking the first joint engagement related to cancer for the Princess of Wales, Kate Middleton, and King Charles. The event celebrated the remarkable 125-year journey of Cancer Research UK, a charity that has close ties to both royals, particularly following the revelations of their own cancer diagnoses in recent years.

This milestone is particularly significant for King Charles, 77, who continues to receive treatment for an undisclosed form of cancer. His diagnosis was made public in February 2024, prompting widespread concern and support. In December of the same year, the monarch provided a hopeful update, indicating that his treatment would be reduced in 2026, a development warmly welcomed by the public.
Princess Kate, 44, announced her cancer diagnosis shortly after her father-in-law’s news, revealing in March 2024 that she too was undergoing treatment. She took a step back from her royal duties to concentrate on her health. By January 2025, she was able to share the uplifting news of her remission following successful chemotherapy.
The bond between King Charles and Princess Kate has reportedly grown stronger due to their shared health challenges. Author Sally Bedell Smith noted that their relationship reflects a profound connection—one comparable to that of a father and daughter. Their similar experiences as patients navigating the complexities of cancer have undoubtedly brought them closer together.
During this recent event, the royals were joined by Queen Camilla and the Duke and Duchess of Gloucester, engaging with researchers, clinicians, and volunteers who are critical to the mission of Cancer Research UK. This significant gathering also launched the charity’s 125th anniversary year, showcasing a commitment to advancing cancer research through collaborative efforts.
Princess Kate marked her attendance in a striking red dress adorned with a white hearts print, a symbol of hope and love. Among the noteworthy interactions during the event, she spoke with Sebastian Bowen, husband of the late Deborah James. James, a journalist who became a prominent advocate for bowel cancer awareness, was posthumously honoured with a damehood by Prince William in recognition of her tireless campaigning before her passing in 2022.
The evening was enriched with immersive installations that highlighted the charity’s past, present, and future innovations in cancer treatment and research. Both King Charles and Queen Camilla took the time to explore visual advancements that underline how technological progress is reshaping the battle against cancer. The event aimed not only to celebrate the charity’s achievements but also to inspire continued support and innovation in this critical field.
King Charles has been actively involved with Cancer Research UK since his health announcement, assuming the role of patron in 2024. His link to the charity was first unveiled during a visit to University College Hospital Macmillan Cancer Centre later that same year, which marked his return to royal engagements following medical advice to step back from public duties.
Significantly, the King’s family members have also played essential roles in supporting the charity. The Duke and Duchess of Gloucester serve as joint presidents, alongside Princess Alexandra, the Honourable Lady Ogilvy, creating a cohesive royal support system for Cancer Research UK’s enduring mission.
Cancer Research UK remains a pivotal organisation, committed to research on over 200 types of cancer. Over the last 125 years, the charity has been instrumental in enhancing our understanding of cancer, advancing detection, and improving treatment and prevention strategies. Its initiatives have played a critical role in doubling the survival rates for cancer over the past five decades within the UK, with a striking statistic noting that eight out of ten cancer patients receiving treatment today are using drugs developed by or in collaboration with the charity.
As the royal family continues to lend their support to Cancer Research UK, they not only highlight the need for ongoing research and funding but also stand in solidarity with countless others facing similar battles against cancer. The joint engagement between the King and the Princess of Wales serves as both a personal message of hope and a broader call for unity in the fight against this pervasive disease.
